LAB Research Canada offers GLP-compliant preclinical studies designed to investigate the absorption, distribution, metabolism and excretion (ADME) to support drug discovery, safety evaluation and clinical development programs.
Equipment
Metabolism cages for all laboratory species CO2 rodent cages (model Metabolica) Fully validated ß-counter (Model: Tri-Carb 2910® TR) Sample Oxidizer (Model 307 Perkin Elmer) API5500 Q Trap for metabolite profiling/identification
Staff
Senior scientists and managers with over 40 years of cumulative experience in contract ADME Supported by experienced dedicated ADME technicians ADME-experienced Study Directors
Services
Mass Balance / excretion studies including CO2 Isotopes used: 14C / 3H
Establishing mass balance and routes of excretion of an administered radioactive drug candidate is important to describe the distribution of the compound and possibly the interpretation of toxicology findings. Understanding the routes of excretion in animals will provide guidance in the evaluation of patients with compromised physiological functions (e.g. hepatic and renal impairment).
Tissue Distribution studies (QTD)
Knowing the time course of a drug candidate's tissue distribution after administration may help in understanding the mechanism and course of action to help explain the observed toxicities. The use of these studies provides an estimate of human exposure to radioactivity (dosimetry) in human radiolabeled mass balance/excretion studies.
QTD studies can be combined with mass balance studies, plasma/blood PK under a single protocol to save time and money.
...................................................................................................................................................................... Species
Rodents Dogs Primates Minipigs
Special Capabilities
Mass Balance studies in minipgs Specialized techniques in PK/Mass balance sampling for non-rodents Fully validated instrumentation to comply with regulatory agencies